Hyperckemia as the only sign of McArdle's disease in a child

Journal of Child Neurology

Volumn 15, Issue 2, 2000, Pages 137-138

  Bruno, Claudio ^a,b   Bertini, Enrico ^c   Santorelli, Filippo M ^c   DiMauro, Salvatore ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CASE REPORT; CREATINE KINASE BLOOD LEVEL; EXERCISE; GLYCOGEN STORAGE DISEASE TYPE 5; HUMAN; MALE; MUSCLE BIOPSY; MYALGIA; PRIORITY JOURNAL;

EID: 0034009709     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380001500216     Document Type: Article

References (21)

1. DiMauro S, Tsujino S: Nonlysosomal glycogenoses, in Engel AG, Franzini-Armstrong C (eds): Myology, 2nd ed, vol 2. New York, McGraw-Hill, 1994, pp 1554-1576.
2. Brumback RA, Feeback DL, Leech RW: Rhabdomyolysis in childhood. A primer on normal muscle function and selected myopathies characterized by disordered energy production. Pediatr Clin North Am 1992;39:821-858.
3. Tsujino S, Shanske S, DiMauro S: Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease). N Engl J Med 1993;329:241-245.
4. DiMauro S, Bruno C: Glycogen storage diseases of muscle. Curr Opin Neurol 1998;11:477-484.
5. DiMauro S, Hartwig GB, Hays AP, et al: Debrancher deficiency: Neuromuscular disorder in five adults. Ann Neurol 1979;5:422-436.
6. Vorgerd M, Kubish C, Burwinkel B, et al: Mutation analysis in myophosphorylase deficiency (McArdle's disease). Ann Neurol 1998;43:326-331.
7. Nevins MA, Sara M, Bright M, Lyon LJ: Pitfalls in interpreting serum creatine phosphokinase activity. JAMA 1973;224:1382-1387.
8. Schneider J, Muhfellner G, Kaffarnik H: Creatine kinase in hyperlipoproteinemic patients treated with clofibrate. Artery 1980;8:164-170.
9. Klein I, Lewey GS: Unusual manifestations of hypothyroidism. Arch Intern Med 1984;144:123-128.
10. Shane E, McClane KA, Olarte M, Bilezikian JP: Hypoparathyroidism and elevated muscle enzymes. Neurology 1984;34:544-547.
11. Brewster LM, de Visser M: Persistent hyperCKemia: Fourteen patients studied in retrospect. Acta Neurol Scand 1988;77:60-63.
12. Rowland LP, Willner J, Cerri C, et al: Approaches to the membrane theory of Duchenne muscular dystrophy, in Angelini C, Danieli GA, Fontanari D (eds): Muscular Dystrophy Research: Advances and New Trends. Amsterdam, Excerpta Medica, 1980, pp 3-13.
13. Sunohara N, Takagi A, Nonaka I, et al: Idiopathic hyperCKemia. Neurology 1984;34:544-577.
14. Galassi G, Rowland LP, Hays AP, et al: High serum levels of creatine kinase: Asymptomatic prelude to distal myopathy. Muscle Nerve 1987;10:346-350.
15. Joy JL, Oh SJ: Asymptomatic hyper-CK-emia: An electrophysiologic and histopathologic study. Muscle Nerve 1989;12:206-209.
16. Tachi N, Wakai S, Yutoh Y, et al: Asymptomatic hyperCKemia: Detection of an isolated carrier of Duchenne muscular dystrophy. J Child Neurol 1990;5:351-353.
17. Lingaraju N, Rosenberg H: Unexplained increases in serum creatine kinase levels: Its relation to malignant hyperthermia susceptibility. Anesth Analg 1991;72:702-705.
18. Frydman M, Straussberg R, Shomrat R, et al: Duchenne muscular dystrophy and idiopathic hyperCKemia segregating in a family. Am J Med Genet 1995;58:209-212.
19. Weglinski MR, Wedel DJ, Engel AG: Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels. Anesth Analg 1997;84:1038-1041.
20. Afifi AK: Idiopathic hyperCKemia revisited, editorial. J Child Neurol 1998;13:251-252.
21. Gospe SM, El-Schahawi M, Shanske S, et al: Asymptomatic McArdle's disease associated with hyperCKemia and absence of myophosphorylase. Neurology 1998;51:1228-1229.